Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volulyte 6% versus Ionolyte in elective abdominal surgery
NL-OMON53031Phase 4Active, not recruiting
- Sponsor
- PRA Health Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypovolemia comparing Volulyte 6% with Ionolyte (2 arms). Primary endpoint: Change in mean estimated glomerular filtration rate. Started Oct 2018; status: active, not recruiting.
02
Drugs
hetastarchIonolyte
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NL-OMON53031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53031.